885681-96-9

Basic information

• Product Name: 4-Bromo-1-(bromomethyl)-2-iodobenzene, alpha,4-Dibromo-2-iodotoluene
• Synonyms: 4-Bromo-1-(bromomethyl)-2-iodobenzene, alpha,4-Dibromo-2-iodotoluene;4-Bromo-2-iodobenzyl bromide 97%;4-Bromo-2-iodobenzylbromide97%;4-Bromo-2-Iodobenzyl Bromide;4-Bromo-1-(bromomethyl)-2-iodobenzene
• CAS NO: 885681-96-9
• Molecular Formula: C₇H₅Br₂I
• Molecular Weight: 375.82707
• Mol File: 885681-96-9.mol

Chemical Properties

• Appearance: /
• Storage Temp.: 2-8°C(protect from light)
• CAS DataBase Reference: 4-Bromo-1-(bromomethyl)-2-iodobenzene, alpha,4-Dibromo-2-iodotoluene(CAS DataBase Reference)
• NIST Chemistry Reference: 4-Bromo-1-(bromomethyl)-2-iodobenzene, alpha,4-Dibromo-2-iodotoluene(885681-96-9)
• EPA Substance Registry System: 4-Bromo-1-(bromomethyl)-2-iodobenzene, alpha,4-Dibromo-2-iodotoluene(885681-96-9)

Safety Data

• Hazardous Substances Data: 885681-96-9(Hazardous Substances Data)

Usage

Uses

Used in Pharmaceutical Industry:
4-Bromo-1-(bromomethyl)-2-iodobenzene, alpha,4-Dibromo-2-iodotoluene is used as an intermediate in the synthesis of pharmaceuticals for its unique reactivity and ability to form complex molecular structures. Its presence of halogen atoms allows for the creation of new chemical bonds and the development of novel drug candidates with potential therapeutic applications.
Used in Dye Industry:
In the dye industry, 4-Bromo-1-(bromomethyl)-2-iodobenzene, alpha,4-Dibromo-2-iodotoluene is utilized as a precursor in the production of various dyes. The presence of bromine and iodine atoms in its structure contributes to the color and stability of the resulting dyes, making it a valuable component in the formulation of colorants for textiles, plastics, and other materials.
Used in Research and Development:
4-Bromo-1-(bromomethyl)-2-iodobenzene, alpha,4-Dibromo-2-iodotoluene is also used in research and development laboratories due to its unique chemical properties. Scientists and researchers leverage its reactivity to explore new chemical reactions and synthesize novel compounds with potential applications in various fields, including materials science, organic chemistry, and medicinal chemistry.
However, it is important to note that due to the potentially hazardous nature of these chemicals, they require careful handling and storage to prevent any adverse effects on human health and the environment. Proper safety measures and protocols should be followed to ensure the safe use of 4-Bromo-1-(bromomethyl)-2-iodobenzene, alpha,4-Dibromo-2-iodotoluene in various applications.

Upstream product

• 1133123-02-0 4-bromo-2- iodobenzoic acid 
• 1261438-69-0 (4-bromo-2-iodophenyl)methanol 
• 39478-78-9 5-bromo-2-methylaniline 
• 106-38-7 para-bromotoluene 
• 260558-15-4 4-bromo-2-iodo-1-methylbenzene 

Downstream Products

• 1279129-86-0 (Z)-1,2-bis(4-bromo-2-iodophenyl)ethene 
• 1261470-87-4 5-bromo-1-iodo-2-benzaldehyde 
• 1601464-27-0 trimethyl((5-bromo-2-vinylphenyl)ethynyl)silane 
• 1601464-01-0 4-bromo-2-ethynyl-1-vinylbenzene 
• 1601464-10-1 6-bromo-2-(5-bromo-2-vinylphenyl)-1,8b-dihydrobiphenylene 
• 1383985-53-2 Methyl 1-(4-bromo-2-iodobenzyl)-4-(difluoromethyl)cyclohexanecarboxylate 
• 1383985-43-0 Ethyl 1-(4-bromo-2-iodobenzyl)-4-(trifluoromethyl)cyclohexanecarboxylate 

Relevant articles and documents

Practical method for preparation of 2-[18F]fluoro-4-boronophenylalanine

2 - Containing radioactive isotopes18 F] Fluoro -4 - boronylphenylalanine18 F [FBPA] A process for the preparation of the same. [18 F-FBPA is an efficient target compound by suggesting a precursor and reaction conditions w

INHIBITORS OF PURINE NUCLEOSIDE PHOSPHORYLASE - SYNTHESIS AND USE THEREOF FOR TREATMENT OF T-CELL ACUTE LYMPHOBLASTIC LEUKEMIA AND LYMPHOMA

The present invention relates to new compounds of general formula I, their synthesis, their pharmaceutically acceptable salts, and their use in treatment of T-cell acute lymphoblastic leukemia and lymphoma.

CuSO4-Catalyzed Tandem C(sp3)-H Insertion Cyclization of Toluenes with Isonitriles to Form Indoles

A CuSO4-catalyzed tandem benzylic C-H insertion cyclization of toluene derivatives and isonitriles is described. The naturally abundant salt CuSO4 serves as a low-cost ligand-free redox catalyst. This reaction provides a practical mo

tBuOK-Promoted Cyclization of Imines with Aryl Halides

A transition-metal-free indole synthesis using radical coupling of 2-halotoluenes and imines via the later-stage C-N bond construction was reported for the first time. It includes an aminyl radical generation by C-H cleaving addition of 2-halotoluenes to imines via the carbanion radical relay and an intramolecular coupling of aryl halides with aminyl radicals. One standard condition can be used for all halides including F, Cl, Br, and I. No extra oxidant or transition metal is required.

CuSO4-Catalyzed dual annulation to synthesize O, S or N-containing tetracyclic heteroacenes

In this work, CuSO4 is utilized as a practical redox catalyst for tandem dual annulation in the synthesis of indole-fused tetracyclic heteroacenes, which are important skeletons in both medicinal chemistry and materials chemistry. The preparation of such skeletons in a convenient and efficient manner is in high demand. This method realizes the modular synthesis of benzofuro-, benzothieno-, and indoloindoles from abundant feedstocks such as 2-halobenzyl halides and nitrile derivatives in up to 99% yields, providing a rapid access to diverse indole-fused heteroacenes with biological or optoelectronic properties.

New preparation method of [F]FBPA

The invention discloses a new preparation method of [F]FBPA. The preparation method comprises: synthesizing an aryl iodide compound containing a BPA core skeleton; synthesizing a standard compound; synthesizing a highly-valent iodine ylide-labeled pre

CHROMANE MONOBACTAM COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS

The present invention relates to monobactam compounds of Formula (I) and pharmaceutically acceptable salts thereof. The present invention also relates to compositions which comprise a monobactam compound of the invention or a pharmaceutically acceptable salt thereof, and a pharmaceutically acceptable carrier. The invention further relates to methods for treating a bacterial infection comprising administering to the patient a therapeutically effective amount of a compound of the invention, either alone or in combination with a therapeutically effective amount of a second beta-lactam antibiotic.

Access to chiral tetrahydrofluorenes through a palladium-catalyzed enantioselective tandem intramolecular Heck/Tsuji-Trost reaction

A palladium-catalyzed enantioselective coupling of 2,5-cyclohexadienyl-substituted aryl iodides and carbon or heteroatom nucleophiles is described. The reaction proceeded via a tandem asymmetric Heck insertion and Tsuji-Trost allylation, enabling the rapi

METHOD FOR PRODUCING 2-FLUORO-4-BORONO-L-PHENYLALANINE, AND A DERIVATIVE OF 2-FLUORO-4-BORONO-L-PHENYLALANINE

The present invention provides a method for producing 2-fluoro-4-borono-L-phenylalanine, and aderivative of 2-fluoro-4-borono-L-phenylalanine. The invention is to prepare and use a compound represented by the following formula. In the formula, R1/su

Dihydrobiphenylenes through ruthenium-catalyzed [2+2+2] cycloadditions of ortho-alkenylarylacetylenes with alkynes

A new synthetic route to dihydrobiphenylenes has been developed. The process involves a mild RuII-catalyzed [2+2+2] dimerization of ortho-alkenylarylacetylenes or its more versatile variant, the Ru-catalyzed [2+2+2] cycloaddition of ortho-ethynylstyrenes with alkynes. Mechanistic aspects of this [2+2+2] cycloaddition are discussed. A new synthetic route to dihydrobiphenylenes involves a mild RuII-catalyzed [2+2+2] dimerization of ortho-alkenylarylacetylenes or its more versatile variant, the Ru-catalyzed [2+2+2] cycloaddition of ortho-ethynylstyrenes with alkynes. The mechanistic aspects of this [2+2+2] cycloaddition are also discussed. Copyright